This observation is of particular interest because ligand-induced RAGE signaling is involved in AD pathological processes, while sRAGE acts as a decoy receptor that antagonizes RAGE-mediated adverse effects (Park et al., 2004; Yan et al., 2009). This evidence concerns the gene AGER and Alzheimer disease.